MICRO2NANO INC.

As of June 30, 2026, MICRO2NANO INC. carries a market capitalization of 45.52B, placing it among publicly traded companies globally. Its enterprise value stands at 45.44B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, MICRO2NANO INC. has 5.92M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 1.46, and the price-to-book ratio stands at 1.65.

As of June 30, 2026, MICRO2NANO INC. trades at an EV/EBITDA multiple of 38.30 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.45 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 45.44B versus a market cap of 45.52B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, MICRO2NANO INC. maintains a current ratio of 3.45, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, MICRO2NANO INC. posted a negative return on equity (ROE) of -9.06, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -4.96, reflecting losses generated across the asset base. The company generates approximately 232.20M in revenue per employee across its workforce of 134.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.66 indicates how many times MICRO2NANO INC. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, MICRO2NANO INC. recorded 1.34B in income tax expense. The company reported a pretax loss of -1.25B and -2.59B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, MICRO2NANO INC.'s stock has gained approximately 2.24% over the past 52 weeks. The 50-day moving average sits at 8,685.20, while the 200-day moving average is 10,482.90.

Over the twelve months ended June 30, 2026, MICRO2NANO INC. generated 31.23B in revenue and converted that into -2.59B in net income, yielding earnings per share of -438.40. EBITDA reached 1.19B, while operating income came in at -907.18M.

As of June 30, 2026, MICRO2NANO INC. holds 9.62B in cash and equivalents against 9.54B in total debt, resulting in a net debt position of 3.84B. Total book value stands at 27.57B, with working capital of 18.96B providing operational flexibility.

MICRO2NANO INC. produced -1.14B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -3.67B in capital expenditures, free cash flow totaled -4.81B - equivalent to -813.35 per share.

Over the twelve months ended June 30, 2026, MICRO2NANO INC. posted a gross margin of 27.85, reflecting its pricing power and cost economics. The operating margin of -2.90 and net profit margin of -8.30 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -10.58: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 7.95, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to MICRO2NANO INC. shareholders.

As of June 30, 2026, MICRO2NANO INC. has an Altman Z-Score of 1.99, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.